NUTX
Nutex Health, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$193.24
−2.25%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+49.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 3, 2026 | Reed Michael Lee · director | M-Exempt | 603 | $0.00 |
| Aug 3, 2026 | Jaumot Frank E · director | M-Exempt | 603 | $0.00 |
| Aug 3, 2026 | Grenas Cheryl Yvonne · director | M-Exempt | 603 | $0.00 |
| Aug 3, 2026 | Saunders Scott J · director | M-Exempt | 603 | $0.00 |
| Apr 24, 2026 | Grenas Cheryl Yvonne · director | A-Award | 823 | $0.00 |
| Apr 24, 2026 | Reed Michael Lee · director | A-Award | 823 | $0.00 |
| Apr 24, 2026 | Saunders Scott J · director | A-Award | 823 | $0.00 |
| Apr 24, 2026 | Jaumot Frank E · director | A-Award | 823 | $0.00 |
| Apr 10, 2026 | Vo Thomas T. · director, officer: Chief Executive Officer | M-Exempt | 4,841 | $0.00 |
| Mar 24, 2026 | Bamburg Wesley Shane · officer: Chief Operating Officer | M-Exempt | 2,411 | $0.00 |
| Mar 23, 2026 | Hosseinion Warren · director, officer: President | M-Exempt | 3,656 | $0.00 |
| Mar 23, 2026 | Hosseinion Warren · director, officer: President | Purchase | 252 | $94 |
| Mar 23, 2026 | Jaumot Frank E · director | Purchase | 150 | $94 |
| Mar 16, 2026 | Montgomery Pamela W. · officer: Chief Legal Officer-Healthcare | M-Exempt | 1,523 | $0.00 |
| Mar 16, 2026 | Montgomery Pamela W. · officer: Chief Legal Officer-Healthcare | Purchase | 79 | $89 |
| Mar 11, 2026 | Chang Michael L. · officer: Chief Medical Officer | M-Exempt | 1,936 | $0.00 |
| Mar 11, 2026 | Chang Michael L. · officer: Chief Medical Officer | F-InKind | 769 | $86 |
| Mar 11, 2026 | Chang Michael L. · officer: Chief Medical Officer | M-Exempt | 2,084 | $0.00 |
| Mar 11, 2026 | Spears Kelvin · director | M-Exempt | 116 | $0.00 |
| Mar 11, 2026 | Spears Kelvin · director | F-InKind | 82 | $86 |
| Mar 11, 2026 | Spears Kelvin · director | M-Exempt | 183 | $0.00 |
| Mar 11, 2026 | Montgomery Pamela W. · officer: Chief Legal Officer-Healthcare | M-Exempt | 1,525 | $0.00 |
| Mar 11, 2026 | Montgomery Pamela W. · officer: Chief Legal Officer-Healthcare | F-InKind | 776 | $86 |
| Mar 11, 2026 | Montgomery Pamela W. · officer: Chief Legal Officer-Healthcare | M-Exempt | 2,084 | $0.00 |
| Mar 11, 2026 | Vo Thomas T. · director, officer: Chief Executive Officer | M-Exempt | 4,841 | $0.00 |
| Mar 11, 2026 | Luqman Elisa V · officer: Chief Legal Officer - SEC | F-InKind | 784 | $86 |
| Mar 11, 2026 | Luqman Elisa V · officer: Chief Legal Officer - SEC | M-Exempt | 2,084 | $0.00 |
| Mar 11, 2026 | Bates Jon Christian · officer: Chief Financial Officer | M-Exempt | 2,667 | $0.00 |
| Mar 11, 2026 | Bates Jon Christian · officer: Chief Financial Officer | M-Exempt | 1,694 | $0.00 |
| Mar 11, 2026 | Luqman Elisa V · officer: Chief Legal Officer - SEC | M-Exempt | 1,525 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 43Increased 50Reduced 28Sold out 131
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 379,355 | May 13, 2026 |
| PERTENTO PARTNERS LLP | Increased | 373,970 | May 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 219,131 | May 15, 2026 |
| AMERICAN CENTURY COMPANIES INC | Increased | 203,450 | May 15, 2026 |
| TOPLINE CAPITAL MANAGEMENT, LLC | Reduced | 177,800 | May 15, 2026 |
| STATE STREET CORP | Increased | 123,177 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 122,113 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 89,571 | May 15, 2026 |
| UBS GROUP AG | Increased | 69,570 | May 5, 2026 |
| WINMILL & CO. INC | New Position | 65,350 | May 14, 2026 |
| VICTORY CAPITAL MANAGEMENT INC | Increased | 45,134 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 42,498 | May 15, 2026 |
| NORTHERN TRUST CORP | Increased | 41,267 | May 14, 2026 |
| ONE PLUS ONE WEALTH MANAGEMENT, LLC | Unchanged | 40,441 | Apr 20, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 39,803 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 3, 2026